Trial intelligence / Profile preview

Lovastatin and Paclitaxel in Refractory or Relapsed Ovarian Cancer

NCT00585052Phase 2Terminated

Sponsor
University of Iowa
Start
Aug 2003
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lovastatin in ovarian cancer, sponsored by University of Iowa. Started Aug 2003; status: terminated.

02

Drugs

lovastatin
03

Conditions

ovarian cancer

Beyond the preview

Go deeper on NCT00585052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00585052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call